广济药业: 关于全资子公司湖北广化制药有限公司公开挂牌增资进展暨完成工商变更登记的公告

Core Viewpoint - Hubei Guangji Pharmaceutical Co., Ltd. has successfully completed the capital increase and business registration changes for its wholly-owned subsidiary, Hubei Guanghua Pharmaceutical Co., Ltd., by introducing strategic investors through a public listing process [1][2][3] Group 1: Transaction Overview - The capital increase involved introducing strategic investors, with a total registered capital increase of RMB 25 million [2] - The strategic investors identified are Hubei Changjiang Medical Industry Investment Co., Ltd. and Huanggang High-tech Industry Investment Group Co., Ltd., contributing RMB 200 million and RMB 50 million respectively [2][3] Group 2: Progress of the Transaction - As of the announcement date, Guanghua Pharmaceutical has completed the business registration changes and received the business license from Huanggang Market Supervision Administration [3][4] - Following the capital increase, Guanghua Pharmaceutical's registered capital is now RMB 35 million, with Changjiang Medical holding 57.14% and Huanggang High-tech holding 14.29% of the shares [4]